Anti-Human PIKE (CT)

Pricing & Details

Product No.P212
Protein
PIKE
Formats AvailableView All
Product Type
Polyclonal Antibody
Applications
IHC FF
,
IHC FFPE
,
WB
Prod No.
Size
Price
Avail.
Qty
Add to cart
P212-20ug
20 µg
$195.00
In stock
Max:
Min: 1
Step: 1
P212-0.1 mg
0.1 mg
$397.00
In stock
Max:
Min: 1
Step: 1
Bulk quantities available. Contact us for pricing.

Data

Antibody Details

Product Details

Reactivity Species
Human
Host Species
Rabbit
Immunogen
PN:P222
Product Concentration
0.5 mg/ml
Formulation
This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Storage and Handling
This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at –20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Specificity
Rabbit Anti-Human PIKE recognizes an epitope near the C-terminus of Human and Mouse PIKE. This polyclonal antibody was purified using affinity chromatography.
Background
Phosphoinositide 3 kinase enhancer (PIKE) is a recently identified nuclear GTPase that interacts with nuclear phosphoinositide 3-kinase (PI3 kinase) to stimulate its lipid kinase activity (1). PIKE exists in multiple isoforms; a shorter C-terminal isoform (PIKE-A) has also been identified as centaurin γ 1 (reviewed in 2). The longest isoform (PIKE-L) has been shown to bind to the adaptor protein Homer and thereby link to metabotropic glutamate receptors, leading to activation of PI3 kinase activity and prevention of neuronal apoptosis.3 Overexpression of PIKE-A enhances Akt activity and promotes cancer cell invasion, whereas decreased expression of PIKE-A via dominant negative expression of PIKE-A or PIKE-A knockdown inhibits these processes.4 In many human cancers, expression of PIKE-A is enhanced, leading to increased Akt activity and preventing apoptosis.

Antigen Details

Protein
PubMed

References & Citations

1. Ye, K. et al. (2000) Cell 103:919
2. Jackson, TR. et al. (2000) Trends Biochem. Sci. 25:489
3. Rong, R. et al. (2003) Nat. Neurosci. 6:1153
4. Ahn, JY. et al. (2004) J. Biol. Chem. 279:16441
IHC
IHC
General Western Blot Protocol
Prod No.
Description
P222
P212
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy. Ok